Concepedia

Steven M. Schmid

SM

Statistics

Publications

14

Citations

642

H-Index

13

Active since

1986

Affiliations

Southern Research Institute(Current)

SynZyme Technologies (United States)

Gene Therapy Laboratory

University of Wisconsin–Madison

Rutgers, The State University of New Jersey

Steven M. Schmid is an author at Southern Research Institute specializing in cancer pharmacology, oncology, and molecular oncology.

Publications per year

1986–2015

14

Publications

14

SCD1 Inhibition Causes Cancer Cell Death by Depleting Mono-Unsaturated Fatty Acids

Paul Mason, Beirong Liang, Lingyun Li et al. · PLoS ONE · 2012 · 171 citations · Full text

, , +17

Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.

Joan H. Schiller, Debra S. Groveman, Steven M. Schmid et al. · PubMed · 1986 · 67 citations

, , +8

The mechanism of action of docetaxel (Taxotere®) in xenograft models is not limited to bcl-2 phosphorylation

Lisa A. Kraus, Shanti K. Samuel, Steven M. Schmid et al. · Investigational New Drugs · 2003 · 57 citations

, , +10

Mechanism of Action of the Microtubule-Targeted Antimitotic Depsipeptide Tasidotin (Formerly ILX651) and Its Major Metabolite Tasidotin C-Carboxylate

Anasuya Ray, Tatiana Okouneva, Tapas Manna et al. · Cancer Research · 2007 · 54 citations · Full text

, , +17

Preclinical Antitumor Activity of 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine (C1-F-Ara-A)

William R. Waud, Steven M. Schmid, John A. Montgomery et al. · Nucleosides Nucleotides & Nucleic Acids · 2000 · 51 citations

, , +9

1–5 of 14